MEDICLIN focuses on patient safety and innovative concepts in rehabilitation

The effects of the coronavirus pandemic are burdening the business development in the first quarter of 2021

MEDICLIN AG: Massive loss of earnings due to corona pandemic – outlook 2021 afflicted with uncertainties – effective protective shield is necessary.

MEDICLIN has achieved the revised targets for 2020

The Board of Management of MEDICLIN will be expanded − Dr. York Dhein will join on April 1st, 2021

3 pm: Ad hoc-Release Disclosure of an inside information acc. to Article17 MAR of the Regulation (EU) No 596/2014: MEDICLIN publishes forecast for fiscal year 2020

Corona-related precautious free capacities reserved as a precaution in the second quarter of 2020 led to a decline in sales and earnings in the Group - a reliable forecast for the 2020 financial year is not yet possible

Free bed capacity led to a decline in sales and earnings in the first quarter of 2020 – no reliable forecast for the 2020 financial year yet possible

9.59 am: Ad hoc-Release Disclosure of an inside information acc. to Article17 MAR of the Regulation (EU) No 596/2014: MEDICLIN publishes preliminary figures for the first quarter of 2020 and, due to the Corona pandemic, lowers its forecast for 2020

MEDICLIN is satisfied with the 2019 financial year - the outlook for 2020 is fraught with uncertainty